<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Blum, Walter</dc:creator>
  <dc:creator>Pecze, László</dc:creator>
  <dc:creator>Wörthmüller Rodriguez, Janine</dc:creator>
  <dc:creator>Steinauer, Martine</dc:creator>
  <dc:creator>Schwaller, Beat</dc:creator>
  <dc:date>2018-04-27</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">The calcium-binding protein calretinin (gene name: CALB2) is currently considered as  the most sensitive and specific marker for the diagnosis of malignant mesothelioma  (MM). MM is a very aggressive tumor strongly linked to asbestos exposure and with  no existing cure so far. The mechanisms of calretinin regulation, as well as its distinct  function in MM are still poorly understood.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/306773</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/306773/files/sch_rcm.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1186/s12885-018-4385-7</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>BMC Cancer. - 2018, vol. 18, p. 475</dc:source>
  <dc:subject>info:eu-repo/classification/udc/57</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">Regulation of calretinin in malignant mesothelioma is mediated by septin 7 binding to the CALB2 promoter</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>